Two cases of nonconvulsive status epilepticus in association with tiagabine therapy

Epilepsia

Volumn 40, Issue 8, 1999, Pages 1159-1162

  Ettinger, Alan B ^a   Bernal, Oscar G ^a   Andriola, Mary R ^a   Bagchi, Sugata ^a   Flores, Patricia ^a   Just, Cecille ^a   Pitocco, Christine ^a   Rooney, Terrance ^a   Tuominen, John ^a   Devinsky, Orrin ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

Medication induced seizures; Nonconvulsive status epilepticus; Tiagabine

Indexed keywords

TIAGABINE;

ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; FOCAL EPILEPSY; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; ANTICONVULSANTS; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; NIPECOTIC ACIDS; STATUS EPILEPTICUS;

EID: 0032774260     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00835.x     Document Type: Article

References (14)

1. Rowan AJ, Uthman B, Ahmann P, et al. Safety and efficacy of three dose levels of tiagabine HCl versus placebo as adjunctive treatment for complex partial seizures Epilepsia 1994;35(suppl 8): 54.
2. Sachdeo R, Leroy R, Krauss G, et al. Safety and efficacy of BID and QID dosing with tiagabine HCl versus placebo as adjunctive treatment for partial seizures Neurology 1995;45(suppl 4):A202.
3. Leach JP, Brodie MJ. Tiagabine. Lancet 1998;351:203-7.
4. Osorio J, Burnstine, TH, Remler B, Manon-Espavillat R, Reed RC. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients. Epilepsia 1989;30:230-4.
5. Johnsen SD, Tarby TJ, Sidell D. Carbamazepine-induced seizures. Ann Neurol 1984;16:392-3.
6. Schapel G, Chadwick D. Tiagabine and non-convulsive status epilepticus. Seizure 1996;5:153-6.
7. Eckardt K, Steinhoff B. Nonconvulsive status epilepticus in two patients receiving tiagabine treatment. Epilepsia 1998;39:671-4.
8. Abbott Laboratories. Tiagabine. Drug insert. North Chicago, IL: Abbott Laboratories, 1997.
9. Shinnar S, Berg A, Hauser WA, et al. Evaluation of the incidence of status epilepticus in association with tiagabine therapy. Epilepsia 1997;38(suppl 3):65.
10. Shinnar S, Treiman D, Sommerville K, et al. Evaluation of spike and wave discharges and complex partial status epilepticus in association with tiagabine therapy. Neurology 1997;48:A39.
11. Coenen AM, Blezer EH, van Luijtelaar EL. Effects of the GABAuptake inhibitor tiagabine on electroencephalogram spike-wave discharges and behaviour in rats. Epilepsy Res 1995;21:89-94.
12. Hosford DA, Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 1997;38:408-14.
13. Walton NY, Gunawan S, Treiman DM. Treatment of experimental status epilepticus with GABA uptake inhibitor, tiagabine. Epilepsy Res 1994;19:237-44.
14. Kaplan PW. Nonconvulsive status epilepticus. Semin Neurol 1996; 16:33-40.